Project Grant R21NS139078

Award Date 7/15/24
Completion Date 6/30/26
Dollars Obligated $388K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90095, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $147,519.00 to the University of Arkansas to develop a portable, battery-powered backpack sampling platform for neuroscience research. The key products to be delivered include: (1) a custom microcontroller board, (2) a fluidic pumping mechanism, (3) a microfluidic...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $348,373 to Central Michigan University to develop novel biosensors and genetic circuits for targeted modulation of neuroinflammation. The research aims to create bioluminescent biosensors that can detect and report on dynamic changes in inflammatory signals in the...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support the development and evaluation of a luminescence-based biosensor to non-invasively measure UBE3A activity in the brain. The $233,250 award to the University of North Carolina at Chapel Hill aims to improve the sensitivity of this biosensor and validate its use in primary cells and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $301,172 to the University of Oregon to develop scalable fabrication methods for high-density amorphous silicon carbide microelectrode arrays. The goal is to create flexible, high-quality neural recording devices that can be easily implanted in the brain without...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), provides $449,684 to The Regents of the University of California, San Francisco (UCSF) to conduct research on mapping the functional G protein-coupled receptor (GPCR) landscape and its signaling consequences in neurons. The goal of the project is to determine which...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, is for the development of a new brain recording system called "mesoscopic electrophysiology" for non-human primates. The goal is to create a 3D grid of 1,920 electrodes across an entire brain hemisphere that can provide high-resolution spatial and temporal data to...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $419,038 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program to the University of North Dakota. The purpose of this 3-year grant, awarded on September 17, 2024, is to develop a miniature selective plane illumination fluorescence microscope for high-resolution volumetric imaging of astrocyte activity in freely behaving mice. The...
This $566,015 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), supports the University of Utah's development of a configurable and thermo-responsive intracortical electrode array platform using 3D printing and gallium-based liquid metal electrode materials. The goal is to create a next-generation implantable neural...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program aims to develop a miniaturized imaging device, referred to as a "synthetic mesoscope," that can record neuronal activity across the entire cranium of freely-behaving mice with near-single-cell resolution. The total award amount is $1,558,808, with a project period from June 15, 2024...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $481,250 to President and Fellows of Harvard College to develop a synthetic biological system for subcellular manipulation of RNAs and proteins in subtype-specific neurons. The goal is to enable investigation of the molecular mechanisms regulating neural circuit...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to engineer a highly selective and active G-aminobutyric acid (GABA) oxidase enzyme. The $388,158 grant, awarded on July 15, 2024, with an ultimate completion date of June 30, 2026, will fund the development of a high-performance, implantable, electroenzymatic GABA microsensor. This sensor technology will enable real-time monitoring of GABA, the brain's primary inhibitory neurotransmitter, at the cellular level. The project will leverage the University of California, Los Angeles' (UCLA) expertise in protein engineering, neuroscience, and implantable microsensor construction to create a tool that will help illuminate the function of critical neural circuitry. The goal is to address the current lack of technology to monitor GABA transients, which are associated with neurological disorders affecting approximately 25 million people in the US.

Generated 6/10/25, 3:40 AM